Yikes 😬

$bluebird bio (BLUE.US)$ robbing Peter to pay Paul. Paying that many millions of dollars just to fire a quarter of the work force hoping to limp along just long enough for their plan to work out 100% as envisioned? Not a gamble I'd take given the crazy extra manufacturing challenges for genetic treatments. Hopefully an angel investor will swoop in before they have to start selling the office sinks 😞